Barnaby May
Fortuna: 1 M $ al 31/08/2026
Fortuna: 1 M $ al 31/08/2026
Barnaby C.
H.
May is currently the Chief Scientific Officer at Aroa Biosurgery Ltd. He previously worked as the Scientific Director at Inpro Biotechnology, Inc. Dr. May obtained a doctorate degree from the University of Canterbury.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AROA BIOSURGERY LTD 0,95 % | 16/06/2025 | 3.272.775 ( 0,95 % ) | 1 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AROA BIOSURGERY LIMITED | Director Técnico/Científico/I+D | 01/06/2015 |
| Empresas | Cargo | Fin |
|---|---|---|
Inpro Biotechnology, Inc. | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Inpro Biotechnology, Inc. | |
University of Canterbury
University of Canterbury Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aroa Biosurgery Ltd.
Aroa Biosurgery Ltd. Medical SpecialtiesHealth Technology Develops medical devices for soft tissue regeneration and cellular scaffolding | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.